Cresset Asset Management, LLC
Position in PVLA — Palvella Therapeutics, Inc.
CIK 1761013
Chicago, IL
Position in PVLA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,478,349
+$282,076 QoQ
Shares Held
11,860
+3.8% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 89.78077571669478.ToString("F0")%
Shared 0.ToString("F0")%
None 10.219224283305229.ToString("F0")%
Common Shares in PVLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cresset Asset Management, LLC holds $84,055,568 across 41 Biotechnology names. PVLA ranks #8 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
739,191 | $38,630,121 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
259,397 | $16,764,828 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,860 | $3,509,804 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
13,633 | $2,577,318 | |
| 5 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
86,063 | $2,130,919 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
72,435 | $2,028,904 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,537 | $1,960,187 | |
| 8 | PVLA |
Palvella Therapeutics, Inc.
This page
|
11,860 | $1,478,349 |
All Filings in PVLA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,478,349 | 11,860 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,196,273 | 11,429 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,092,310 | 17,424 | Shares | Sole | 2026-01-22 | |
| 2025-06-30 | $471,333 | 20,911 | Shares | Sole | 2026-01-22 | |
| 2025-03-31 | $585,298 | 20,911 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $250,932 | 20,911 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||